Kezar Life Sciences Organization
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
%20.jpg)
Industry:
PharmTech
Investment Stage:
N/A
Investors Number:
10
Technology:
Data-driven Technologies
Last Funding Type:
Series B
Headquarters:
South San Francisco, California, United States
Founded Date:
2015
Investor Type:
Healthcare Company
Funding Status:
IPO
Total Funding:
$78.3M
Estimated Revenue:
$1M to $10M
Number Of Exists:
N/A
Employee Number:
11-50